Eicosapentaenoic acid (EPA) in reducing secondary cardiovascular events in hypercholesterolemic Japanese patients.
Kohro
Takahide
T
Yamazaki
Tsutomu
T
D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control*; D008078:Cholesterol, LDL / Q000097:blood; D015118:Eicosapentaenoic Acid / Q000627:therapeutic use*; D015525:Fatty Acids, Omega-3 / Q000627:therapeutic use; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000150:complications*; D015994:Incidence; D007564:Japan / Q000453:epidemiology
D008078:Cholesterol, LDL; D015525:Fatty Acids, Omega-3; D015118:Eicosapentaenoic Acid